Repligen’s $1.5B BioLife Acquisition Fits a Bigger Shift in Biotech M&A -( $BLFS $JPM $RGEN ) by John F. Heerdink, Jr. 6 hours ago 49Views 0Likes Repligen’s (REGN) $1.5 billion purchase of BioLife Solutions (BLFS) lands in the middle of a biotech M&A market that is getting bigger, faster, and a bit more strategic than the old “buy the science and hope for the best” model. The deal… Read more
